Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 35385091.
- Also identified by DOI 10.1001/jamanetworkopen.2022.6479 and PMC identifier 8987900.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This economic evaluation study assesses the clinical benefit of novel drugs approved in 2018 and 2019 and examines whether drugs approved with special regulatory designations appear to provide meaningful therapeutic value.
Medical subject headings
- Drug Approval